News 
Market Data 
Discover
Replies to post #7592 on Algernon Pharmaceuticals Inc (AGNPF)
04/19/20 9:11 AM
But the crazy part is that this is just the beginning for coronavirus stocks.
What has been the significant factor for making money with coronavirus stocks? Being early.
The Biggest Objective For Investing: Buy Low, Sell High...
...are there any left to watch that haven't been discovered by the masses yet?
The answer is YES!
Companies like Algernon Pharmaceuticals Inc. (AGNPF) (CSE:AGN) are still flying under the radar; but not for long. While the hunt is on with investors constantly scouring the web for any company with "coronavirus" or "COVID-19" as a keyword on major financial sites, Algernon Pharmaceuticals Inc. (AGNPF) (CSE:AGN) has only just begun to gain exposure. But it won't stay "unknown" for long.
Of course, there's fundamental risk when investing at the early stages of any company, but there is also the potential of GREAT REWARD as we've clearly seen!
Algernon Stands Toe To Toe With Roche, Merck & More
Algernon conducted two independent studies showing that Ifenprodil outperformed the world's leading two treatments for IPF:
Boehringer Ingelheim's Nintedanib; and
Roche's Pirfenidone
Where Does COVID-19 Come Into Play & Why Is Now The Time For Algernon?
Why Algernon Pharmaceuticals Inc. (AGNPF) (CSE: AGN)
1.Algernon Pharmaceuticals Inc. (AGNPF) (CSE:AGN) is one of the few companies still flying under the radar of the masses, potentially giving one of the last "ground floor" looks at a coronavirus stock before a pending breakout
2. Algernon Pharmaceuticals Inc. (AGNPF) (CSE:AGN) already has a proven drug that has a strong safety history and was developed by one of the top names in biotech, Sanofi.
3. Not only has it been presented to the US FDA, but Algernon Pharmaceuticals Inc. (AGNPF) (CSE:AGN) has been working to advance Ifenprodil into multiple phase 2 human trials in Australia, Canada, and South Korea.
4. Algernon Pharmaceuticals Inc. (AGNPF) (CSE:AGN) has already received positive Feedback from U.S. FDA for Ifenprodil COVID-19 Human Trial
5. While early names have gone to trade much higher, the next round of coronavirus stocks could be offering immediate opportunity, now.
